Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Evaxion Biotech
Evaxion Announces Business Update and First Quarter 2024 Financial Results
May 28, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection
April 02, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion Announces Business Update and Full Year 2023 Financial Results
March 27, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform
March 19, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations
February 29, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD
February 20, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion Regains Compliance with Nasdaq Minimum Bid Price Requirement
February 07, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion Announces Closing of $15 Million Public Offering
February 06, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion Biotech Announces Pricing of $15 Million Public Offering
February 01, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets
January 24, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion Announces Completion of ADS Ratio Change
January 22, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion Announces Plan to Implement ADS Ratio Change
January 08, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion Biotech Announces Closing of Private Placement
December 21, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion Announces Business Update and Third Quarter 2023 Financial Results
December 19, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion Biotech Announces Private Placement Financing
December 19, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine Concept
November 28, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion Presents Proof-of-Principle for Its Unique AI Model Predicting Responses to Cancer Immunotherapy
November 15, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion Shares Latest EVX-01 Phase 2 Clinical Data in Webinar with Key Opinion Leader Adnan Khattak
November 06, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion Announces Encouraging Initial Phase 2 Clinical Data on Its Personalized Cancer Vaccine EVX-01
October 31, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
New and Exciting Clinical Data on Evaxion’s AI-Immunology™-Based Personalized Cancer Vaccines to be Presented
October 26, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
October 05, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea
September 20, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion expands preclinical bacterial vaccine pipeline in collaboration with leading pharmaceutical company
September 18, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Revolutionizing Vaccine Discovery: New Data Validates Evaxion AI Platform, Offering Promise to Reduce Risk and Cost in Infectious Disease Vaccine Development
September 11, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion announces Executive Management Changes to strengthen the AI-strategy
August 29, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion Announces Business Update and Second Quarter 2023 Financial Results
August 18, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion announces financing commitments totaling up to USD 20 million with Negma Group
August 01, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion presents promising results on EVX-B1, an AI-designed vaccine against Staphylococcus aureus
July 31, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial
June 03, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Evaxion Announces Business Update and First Quarter 2023 Financial Results
May 31, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Tickers
EVAX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit